Studies have shown that variations in the GIPR gene are linked to cardiovascular disease and metabolic syndrome characteristics, which supports this idea [110]
Daniele G, Iozzo P, Molina-Carrion M, Lancaster J, Ciociaro D, Cersosimo E, et al
Food and Drug Administration (FDA) for reducing cardiovascular and kidney disease risk after a major study showed significantly lower rates of heart attack and stroke among people with type 2 diabetes and established atherosclerosis
Its triple agonist mechanism offers superior efficacy compared to existing therapies, with potential benefits for NAFLD and cardiovascular health
Formulated to double GLP-1 levels, curb cravings and debloat in 30 minutes.** Includes best-selling flavors Strawberry Lemon, Pineapple Passion Fruit and limited edition Peach Iced Tea with 100mg of caffeine for natural energy.* Subscribe & Save 20% Ships monthly.Modify your box, pause or cancel at any time
92 In vitro studies and gene expression analysis support the ability of PLLA to stimulate adipokine expression, type 4 and 6 collagen production, and greater adipogenesis compared to CaHA
